Events

The Antibody and Bioresource Core Facility (ABCF) supports researchers by making it easier for them to develop new monoclonal antibodies (MAbs). As an informational resource as well as service provider, the facility collaborates closely with faculty from MSK and Rockefeller University. It also supports Weill Cornell Medicine researchers as third-party clients.

Attend this virtual interview to discover more about the core facility and how it can support your project. The 45-min interview will be followed by a 15-minute Q&A session for the audience.

Join us to discover ABCF’s resources and capabilities, including:

• Generating custom MAbs
• Distributing cell lines and hybridomas developed at MSK and RU
• Performing mycoplasma testing

Interviewers

Loren A. Busby, CFA, Director, Weill Cornell Medicine BioVenture eLab

Carlo Yuvienco, PhD, Director, Ford Center Incubator @ The Rockefeller University

Featured Guest

Frances Weis-Garcia, PhD ’96, Director, Bi-Institutional Antibody and Bioresource Core Facility

Register here. 

Making a change to pursue your dream, turn an idea into a business, and go for it is scary. How have others taken the leap? Hear from a live panel of Cornellians who made the career transition to entrepreneurship. Learn about where they started, their practical and personal processes, and where they are now.

Join us for a networking reception, panel discussion with audience Q&A, and CEN’s trademark “Open Mic,” where YOU can give your 30-second elevator pitch. What better way to start your entrepreneurial journey?!

Featuring:

• Chris Donohoe ’09, Executive Coach (moderator)
• Marissa Saporta ’99, Co-Founder of Gorilla Commerce
• Siwat Siengsanaoh MBA ’15, Co-Founder, Recoup Beverage, Inc.
• Lauren Berson ’04, CEO & Co-Founder, Conceive

Register now. 

Back by popular demand and with the specific aim to cover more intermediate biodesign concepts, this workshop will teach you techniques to generate ideas and physical prototypes for medical device products and education models.

Building on prior 3D printing classes, this program will cover:

• Biodesign concepts to generate ideas
• Expanded 3D printing applications
• Q&A with speakers

Speakers:

NatalieDeana Badillo: 3rd year medical student at Weill Cornell Medicine who possesses a biomedical engineering background. Natalie is also a member of the Biomedical Engineering Society and is President of the Arts & Crafts & 3D Printing Club at Weill Cornell Medicine.

Ana Krieger, M.D., MPH: Chief of Sleep Neurology and Professor of Clinical Medicine in the Departments of Medicine, Neurology and Genetic Medicine at Weill Cornell Medicine. Dr. Krieger is also Co-Founder of BioSleep Technologies and is an experienced user of WCM’s biodesign/3D printing resources.

Register here. 

There’s a lot of buzz these days around the role that AI will play in pharmaceutical R&D – from target identification to therapeutic design and optimization, from patient stratification to clinical trial design and site selection, and beyond.

So what’s real, and what’s just hype?

Join JLABS for an engaging panel discussion – featuring representatives from the pharmaceutical industry, the startup world and the investor community – focused on how AI is driving the discovery, development and delivery of innovative medicines today, and what the future holds in this rapidly-evolving space. Followed by an exciting celebratory reception to commemorate JLABS at NYC Six-Year Anniversary!

RSVP here. 

Led by the NSF I-Corps Hub: Interior Northeast (IN I-Corps), these free NSF I-Corps Regional Courses are designed for university-based STEM researchers and early-stage founders interested in evaluating the market potential of their technology and learning valuable entrepreneurial skills.

In this month-long virtual course (July 8 - August 7), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit. 

Applications will be reviewed on a rolling basis. Apply now. 

Application closes on Wednesday, June 12. Questions? Contact icorps@cornell.edu or visit www.in-icorps.org/regional-courses. 

Invent Together presents a virtual discussion with Erin Kelley, Genna Hibbs, and Maria Artunduaga on the importance of building your innovation support network and tips to succeed. Register here. 

Join the greater Weill Cornell Medicine community for the $100K Biomedical Business Plan Challenge Pitch Event. Faculty-led startups will have completed 10 weeks of rigorous instruction by life science professionals and, with the help of over two dozen industry mentors, created their initial business plans. This event provides an opportunity for the BPC startup teams to pitch their ideas to a group of prominent venture capital judges and compete for up to $100,000 in prize money.

We will kick off the evening at 5:30pm in Uris Auditorium, followed by a celebration of academic entrepreneurship and innovation in Griffis Faculty Lounge. Register here.

A new generation of human model systems are coming to the forefront of drug development, including novel organoid, microphysiological and in silico platforms. With the passage of the FDA Modernization Act 2.0 in 2022, these cutting-edge systems are poised to gain increasing scientific, commercial and regulatory acceptance in replacing data traditionally sought from animal models. But how far can these systems go in displacing animals, and what commercial and regulatory challenges stand in their path?

Join us as we convene a panel of experts in alternative human model systems to discuss their changing role in science and business. 

Panelists:
•    Lowry Curley, Ph.D., Co-Founder and CEO of Axosim
•    Krista Durney, Ph.D., Associate Director, Innovation & Business Development at Valo Health
•    Kristin Bircsak, Ph.D., Principal Scientist at MIMETAS
•    Iris Bica, Business Development & Licensing Associate at Weill Cornell Medicine (Moderator)

Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Officer.

The May 16th office hours will be hosted by James Bellush, Ph.D, Manager of Scientific Scouting. James is a trained molecular biologist with 10+ years of life sciences experience, specifically focused on drug development, biotech investing, and startup company operations. Before joining the CTL at Weill Cornell team, he was leading scientific diligence, preclinical development, commercial analysis and alliance management for a New York City based biotech venture capital firm. In his current role, James supports a broad portfolio of translational research projects at Weill Cornell through various mechanisms which include sourcing external funding opportunities, establishing biopharma research collaborations and helping advance drug candidates to partnership-ready stages.

Register here for your 30-minute private session with James. 

The BioVenture eLab, a part of Weill Cornell Medicine Enterprise Innovation, invites you to learn about how Weill Cornell Medicine faculty entrepreneurs can take advantage of the $100K Biomedical Business Plan Challenge accelerator.

Join our virtual event to hear from two featured entrepreneurs who have participated in the Business Plan Challenge accelerator.

You'll learn specifically how the accelerator helped these successful founders:

• Create their initial business plans
• Form relationships with advisors & service providers
• Advance their projects with introductions to grant writers and financing sources

The panel features:

Evi Giannakakou, PhD - Professor of Pharmacology in Medicine Weill Cornell Medicine; Co-Founder of ARMA Bio

Marc Schiffman, MD - Assistant Professor of Clinical Research, Radiology Weill Cornell Medicine; Co-Founder of VoiceLove LLC